BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25697826)

  • 21. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis.
    Collard JF; Côté F; Julien JP
    Nature; 1995 May; 375(6526):61-4. PubMed ID: 7536898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis.
    Sasaki S
    J Neuropathol Exp Neurol; 2011 May; 70(5):349-59. PubMed ID: 21487309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS.
    Sun H; Kawahara Y; Ito K; Kanazawa I; Kwak S
    J Neurochem; 2006 Aug; 98(3):782-91. PubMed ID: 16893420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A neurotoxic peripherin splice variant in a mouse model of ALS.
    Robertson J; Doroudchi MM; Nguyen MD; Durham HD; Strong MJ; Shaw G; Julien JP; Mushynski WE
    J Cell Biol; 2003 Mar; 160(6):939-49. PubMed ID: 12642616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motor neuron disease/amyotrophic lateral sclerosis--lessons from ubiquitin.
    Bergmann M
    Pathol Res Pract; 1993 Sep; 189(8):902-12. PubMed ID: 8302713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons.
    Mu X; He J; Anderson DW; Trojanowski JQ; Springer JE
    Ann Neurol; 1996 Sep; 40(3):379-86. PubMed ID: 8797527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential vulnerability of two subsets of spinal motor neurons in amyotrophic lateral sclerosis.
    Wetts R; Vaughn JE
    Exp Neurol; 1996 Oct; 141(2):248-55. PubMed ID: 8812158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium: the Darth Vader of ALS.
    Appel SH; Beers D; Siklos L; Engelhardt JI; Mosier DR
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S47-54. PubMed ID: 11465925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kennedy's disease: a lower motor neuron model to identify upper motor neuron physiology in ALS.
    Eisen A
    Clin Neurophysiol; 2008 May; 119(5):971-2. PubMed ID: 18308629
    [No Abstract]   [Full Text] [Related]  

  • 30. GAP-43 gene expression is increased in anterior horn cells of amyotrophic lateral sclerosis.
    Parhad IM; Oishi R; Clark AW
    Ann Neurol; 1992 Jun; 31(6):593-7. PubMed ID: 1387517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GluR2 AMPA receptor subunit expression in motoneurons at low and high risk for degeneration in amyotrophic lateral sclerosis.
    Laslo P; Lipski J; Nicholson LF; Miles GB; Funk GD
    Exp Neurol; 2001 Jun; 169(2):461-71. PubMed ID: 11358459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
    Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
    Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration.
    Haenggeli C; Kato AC
    Neurosci Lett; 2002 Dec; 335(1):39-43. PubMed ID: 12457737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis.
    Miyazaki K; Ohta Y; Nagai M; Morimoto N; Kurata T; Takehisa Y; Ikeda Y; Matsuura T; Abe K
    J Neurosci Res; 2011 May; 89(5):718-28. PubMed ID: 21337372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study.
    Marcuzzo S; Zucca I; Mastropietro A; de Rosbo NK; Cavalcante P; Tartari S; Bonanno S; Preite L; Mantegazza R; Bernasconi P
    Exp Neurol; 2011 Sep; 231(1):30-7. PubMed ID: 21620832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synaptotagmin 13 is neuroprotective across motor neuron diseases.
    Nizzardo M; Taiana M; Rizzo F; Aguila Benitez J; Nijssen J; Allodi I; Melzi V; Bresolin N; Comi GP; Hedlund E; Corti S
    Acta Neuropathol; 2020 May; 139(5):837-853. PubMed ID: 32065260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Peters OM; Lewis EA; Osterloh JM; Weiss A; Salameh JS; Metterville J; Brown RH; Freeman MR
    Hum Mol Genet; 2018 Nov; 27(21):3761-3771. PubMed ID: 30010873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression.
    Osborn TM; Beagan J; Isacson O
    Neurobiol Dis; 2018 Feb; 110():218-230. PubMed ID: 29113829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of Group I metabotropic glutamate receptors in motoneurons at low and high risk for degeneration in ALS.
    Laslo P; Lipski J; Funk GD
    Neuroreport; 2001 Jul; 12(9):1903-8. PubMed ID: 11435920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS).
    Wong NK; He BP; Strong MJ
    J Neuropathol Exp Neurol; 2000 Nov; 59(11):972-82. PubMed ID: 11089575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.